Trump Drug Tariffs: New Order Impacts Medicine Costs
Trump’s Pharmaceutical Tariffs: A Harbinger of Reshoring and Supply Chain Revolution Over 80% of pharmaceutical ingredients used in the United States are manufactured abroad, primarily in China and India. This reliance, long accepted as a cost-saving measure, is now facing a dramatic re-evaluation. Recent actions by the Trump administration, imposing new tariffs on certain pharmaceuticals … Read more